NCT02383212 2020-01-27Study of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesRegeneron PharmaceuticalsPhase 1 Completed398 enrolled
NCT01287520 2019-02-25A Study of LY2090314 in Patients With Advanced or Metastatic CancerEli Lilly and CompanyPhase 1 Completed41 enrolled 28 charts
NCT01296568 2019-01-07C14 Study in Oncology Patients With Advanced and/or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Completed3 enrolled 13 charts